The Food and Drug Administration (FDA) has approved Tecentriq, in combination with carboplatin and etoposide for the first-line treatment of patients suffering from extensive-stage small cell lung cancer. Out of total lung…
Everything about lung cancer is here.
The Food and Drug Administration (FDA) has approved Tecentriq, in combination with carboplatin and etoposide for the first-line treatment of patients suffering from extensive-stage small cell lung cancer. Out of total lung…